CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis-Reference-Cited by-同舟云学术

CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis

Published:2013-06-28 Issue:9 Volume:62 Page:1475-1484
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Charbonneau Bridget,Wang Alice H.,Maurer Matthew J.,Asmann Yan W.,Zent Clive S.,Link Brian K.,Ansell Stephen M.,Weiner George J.,Ozsan Nazan,Feldman Andrew L.,Witzig Thomas E.,Cunningham Julie M.,Dogan Ahmet,Habermann Thomas M.,Slager Susan L.,Novak Anne J.,Cerhan James R.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-013-1452-4.pdf

Reference42 articles.

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1):10–29. doi: 10.3322/caac.20138

2. Morton LM, Wang SS, Cozen W, Linet MS, Chatterjee N, Davis S, Severson RK, Colt JS, Vasef MA, Rothman N, Blair A, Bernstein L, Cross AJ, De Roos AJ, Engels EA, Hein DW, Hill DA, Kelemen LE, Lim U, Lynch CF, Schenk M, Wacholder S, Ward MH, Hoar Zahm S, Chanock SJ, Cerhan JR, Hartge P (2008) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 112(13):5150–5160. doi: 10.1182/blood-2008-01-133587

3. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M (1996) A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87(6):1037–1047

4. Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD, Browning JL, Lipp M, Cyster JG (2000) A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406(6793):309–314. doi: 10.1038/35018581

5. Kurtova AV, Tamayo AT, Ford RJ, Burger JA (2009) Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting. Blood 113(19):4604–4613. doi: 10.1182/blood-2008-10-185827

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I clinical trial of CD19 CAR-T cells expressing CXCR5 protein for the treatment of relapsed or refractory B-cell lymphoma;2023-01-12

2. Several genetic variants associated with systemic sclerosis in a Chinese Han population;Clinical Rheumatology;2022-10-27

3. Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer;Cancers;2022-01-07

4. CXCL13 in Cancer and Other Diseases: Biological Functions, Clinical Significance, and Therapeutic Opportunities;Life;2021-11-23

5. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity;Cancer and Metastasis Reviews;2021-05-06